Artisan Partners Limited Partnership Maxcyte, Inc. Transaction History

Artisan Partners Limited Partnership

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$3.69 - $5.35 $10,689 - $15,498	2,897 Added 0.23%	1,243,493 $5.71 Million
Q1 2023 May 11, 2023	SELL	$4.03 - $5.89 $12,214 - $17,852	-3,031 Reduced 0.24%	1,240,596 $6.14 Million
Q4 2022 Feb 10, 2023	SELL	$4.92 - $7.4 $134,330 - $202,042	-27,303 Reduced 2.15%	1,243,627 $6.79 Million
Q3 2022 Nov 10, 2022	SELL	$4.52 - $6.51 $26,071 - $37,549	-5,768 Reduced 0.45%	1,270,930 $8.26 Million
Q2 2022 Aug 12, 2022	SELL	$3.59 - $6.81 $8,224 - $15,601	-2,291 Reduced 0.18%	1,276,698 $6.04 Million
Q1 2022 May 13, 2022	SELL	$5.26 - $10.84 $8.65 Million - $17.8 Million	-1,644,166 Reduced 56.25%	1,278,989 $8.94 Million
Q4 2021 Feb 11, 2022	SELL	$8.87 - $12.94 $1.34 Million - $1.95 Million	-150,916 Reduced 4.91%	2,923,155 $29.8 Million
Q3 2021 Nov 12, 2021	BUY	$12.21 - $17.2 $37.5 Million - $52.9 Million	3,074,071 New	3,074,071 $37.3 Million

118

65M

600

2.7K

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $368M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Artisan Partners Limited Partnership with notifications on news.